Meeting
2019 Gastrointestinal Cancers Symposium
Long-term outcome of preoperative docetaxel with cisplatin plus S-1 therapy for advanced gastric cancer with extensive nodal metastasis (JCOG1002).
Authors
Shinji Morita
Division of Gastric Surgery, National Cancer Center Hospital, Tokyo, Japan
Shinji Morita , Seiji Ito , Takeshi Sano , Daisuke Takahari , Hiroshi Katayama , Junki Mizusawa , Mitsuru Sasako , Yoichi Tanaka , Takahiro Kinoshita , Masanori Terashima , Atsushi Nashimoto , Hiroki Yamaue , Norimasa Fukushima , Makoto Yamada , Yoshiyuki Fujiwara , Yutaka Kimura , Atsuki Ikeda , Tsunehiro Yoshimura
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Cancers of the Esophagus and Stomach
Track
Cancers of the Esophagus and Stomach
Sub Track
Multidisciplinary Treatment
Clinical Trial Registration Number
UMIN000006069
Citation
J Clin Oncol 37, 2019 (suppl 4; abstr 141)
DOI
10.1200/JCO.2019.37.4_suppl.141
Abstract #
141
Poster Bd #
L13
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Gastrointestinal Cancers Symposium
The new prognostic index of advanced gastric cancer using the data from JCOG1013.
First Author: Daisuke Takahari
Poster
2020 ASCO Virtual Scientific Program
Neoadjuvant chemotherapy plus surgery for high-risk advanced gastric cancer: Long-term results of KDOG1001 trial.
First Author: Kei Hosoda
Poster
2020 Gastrointestinal Cancers Symposium
Survival benefit of conversion therapy after intensive chemotherapy for unresectable metastatic gastric cancer: A propensity score-matched analysis.
First Author: Hiroyuki Ohnuma
Poster
2019 Gastrointestinal Cancers Symposium
Primary results of a randomized two-by-two factorial phase II trial comparing neoadjuvant chemotherapy with two and four courses of cisplatin/S-1 (CS) and docetaxel/cisplatin/S-1 (DCS) as neoadjuvant chemotherapy for locally advanced gastric cancer.
First Author: Takaki Yoshikawa